GERON CORP Restructuring Reserve
GERON CORP (GERN) had Restructuring Reserve of $178.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-08-05
- 2026-06-30: Restructuring Reserve $178.00K.
- 2026-03-31: Restructuring Reserve $3.11M.
- 2025-12-31: Restructuring Reserve $17.03M; Restructuring Reserve as first filed $17.00M.
- 2024-12-31: Restructuring Reserve $0.00.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2026-06-30 | $178.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $3.11M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $17.03M 10-Q · filed 2026-08-05 | $17.00M 10-K · filed 2026-03-02 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |